Jordan's pharmaceutical industry experienced strong double-digit export growth during the first quarter of 2026, signaling a significant boost to the country's industrial sector and noting its increasing competitiveness on the global stage. This impressive performance shows the sector's vital role as a key economic driver for the Hashemite Kingdom. Exports from the pharmaceutical sector increased to an unspecified amount, up from JD125 million in the corresponding period of 2025. This substantial rise in export value reflects a growing demand for Jordanian pharmaceutical products in international markets. Pharmaceutical exports ranked as the second most rapidly growing industrial export category for the quarter, following only mining industries, demonstrating its strong contribution to overall industrial expansion. Fadi Al-Atrash, representative of the Therapeutic Industries and Medical Supplies Sector at the Jordan Chamber of Industry, affirmed this positive trend, stating that "pharmaceutical exports ranked as the second most rapidly growing industrial export category during the first quarter, behind mining industries." He further emphasized the strategic importance of this growth for Jordan's national economy.
Export Growth Drivers and Reach
Jordanian pharmaceutical exports currently reach an extensive network of 85 countries globally, showcasing the sector's broad international footprint and market penetration. This wide distribution network is a testament to the quality and reliability of products manufactured in Jordan. Manufacturers in Jordan produce more than 5,000 distinct pharmaceutical products, encompassing a vast array of medications and medical supplies, which contributes significantly to the sector's broad market presence and ability to meet diverse global health needs. The industry's annual production capacity has reached approximately JD1.5 billion, a figure that not only notes the substantial scale of operations within the country's pharmaceutical landscape but also indicates its potential for further expansion. This impressive capacity allows Jordan to be a significant player in the regional and international pharmaceutical supply chain. The wide array of products and the extensive reach across numerous nations highlight the sector's established position in international markets, reinforcing its reputation as a reliable supplier. This expansion is a key component of the industrial growth observed in Jordan, contributing to job creation and economic diversification.
Sector Infrastructure and Employment
Jordan's pharmaceutical industry operates through nearly 30 manufacturing facilities strategically located across the Kingdom. These advanced facilities form the backbone of the sector's production capabilities, incorporating advanced technologies and adhering to stringent quality standards. The pharmaceutical sector contributes significantly to the national workforce, providing approximately 10,000 direct jobs. This substantial employment figure shows the industry's role as a major employer within Jordan's industrial landscape, offering stable and skilled positions. Women constitute a notable portion of the sector's workforce, accounting for approximately 35 percent of total employment. This significant demographic representation notes the industry's contribution to female employment in technical and industrial roles, fostering economic empowerment and diversity within the workforce. The established infrastructure, coupled with a substantial and skilled workforce, are key elements supporting the sector's continued growth, innovation, and impressive export performance. This strong foundation ensures the industry's sustained development and its ability to meet future demands.
International Recognition and Future Goals
Exports of pharmaceutical preparations, specifically human medicines, increased by a notable 17.6 percent year-on-year, reaching JD147 million in the first three months of 2026. This specific growth in human medicine exports is a critical indicator of the sector's strength and its ability to compete effectively in a highly regulated global market. Pharmaceutical products are among Jordan's fastest-growing industrial exports, reflecting the sector's expanding global footprint and its increasing contribution to the national economy. This consistent growth trajectory positions Jordan as an emerging leader in pharmaceutical manufacturing in the region. Looking ahead, national targets aim to increase pharmaceutical exports to approximately JD2.1 billion by 2033. This ambitious goal shows the country's unwavering commitment to further developing its pharmaceutical manufacturing and export capabilities, with strategic plans in place to achieve this vision.
Jordan has also significantly enhanced its international standing through key regulatory achievements. The country's accession to the Pharmaceutical Inspection Co-operation Scheme (PIC/S) via the Jordan Food and Drug Administration marks a notable step forward in its regulatory alignment. This key move aligns Jordan's regulatory framework with the highest international standards for good manufacturing practices (GMP), thereby facilitating greater market access for its products and bolstering confidence in Jordanian pharmaceutical products globally. The membership reflects a profound commitment to quality assurance, regulatory excellence, and patient safety, further positioning Jordan as a reliable and trustworthy supplier in the international pharmaceutical market. This recognition is expected to open new avenues for trade and collaboration, solidifying Jordan's reputation as a hub for high-quality pharmaceutical production.
